Breakthrough in Breast Cancer Research: 122 Genes Identified in Pregnancy-Associated Breast Cancer
In a significant advancement in the field of oncology, the GEICAM (Spanish Breast Cancer Research Group) has made a groundbreaking discovery that could pave the way for targeted therapies in breast cancer associated with pregnancy. This innovative research, announced on October 18, 2024, highlights the identification of 122 genes that are differentially expressed in pregnancy-associated breast cancer.
The Study and Its Implications
The GEICAM research group, renowned for its extensive work in breast cancer, conducted a comprehensive study to understand the genetic underpinnings of breast cancer that occurs during or shortly after pregnancy. This type of breast cancer is often more aggressive and challenging to treat due to its unique biological characteristics.
Read more ->